socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Friday, December 16, 2005

    Eidogen-Sertanty Signs Deal with AstraZeneca
    San Diego-based Eidogen-Sertanty said this week that it has signed a deal with AstraZeneca Pharmaceuticals to provide access to its informatics software. AstraZeneca Boston will use Eidogen-Sertanty's software to assist in drug discovery efforts in the area of cancer and anti-infective therapeutic programs. The company also said this week that it has established a collaboration with San Diego-based Kalypsys to use its computational drug discovery platforms for discovery of novel small molecules for anti-inflammatory indications. Eidogen-Sertanty is developing bioinformatics software for managing protein structural data and other areas. The company is backed by Tavistock, HighBAR Ventures, The Athenaeum Fund, and the Band of Angels.
    posted on Friday, December 16, 2005

    Related companies:
    Eidogen-Sertanty

    Related stories:
    > Eidogen-Sertanty Licenses Software To Cephalon
    > Eidogen Licenses Software to Boehringer Ingelheim
    > Arrowhead Research Appoints CFO
    > Memeo Signs Bundling Deal With WD
    > MySpaceTV Signs Deal With BBC Worldwide

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, September 5, 2008
    Thursday, September 4, 2008
    Wednesday, September 3, 2008
    Tuesday, September 2, 2008
    Friday, August 29, 2008